At a glance
ClinicalIndex Comparison RecordN/ACompleted· 450 enrolled
Drug / intervention
SOLTIVE™ Premium SuperPulsed Laser Fiber Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multicenter, Post-Market Clinical Registry to Collect Real-World Evidence on the Clinical Performance of the SOLTIVE™ Laser for Treatment of Kidney or Ureteral Stones
In Brief
A clinical study evaluating SOLTIVE™ Premium SuperPulsed Laser Fiber System for Kidney Stone and Ureteral Stone. Completed, enrolled 450 participants across 7 sites in 3 countries.
Detailed Summary
The purpose of this study is to collect real-world evidence on the performance of the SOLTIVE™ Premium SuperPulsed Laser System for laser lithotripsy in ureteroscopy, percutaneous nephrolithotomy (PCNL) and mini PCNL for kidney and ureteral stones.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKidney Stone, Ureteral Stone
CountriesDenmark, Portugal, United States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedSep 2020
Enrollment StartDec 2020
Primary CompletionFeb 2023
Study CompletionMay 2023
TodayJul 2026
First PostedSep 21, 2020
Enrollment StartDec 1, 2020
Primary CompletionFeb 2, 2023
Study CompletionMay 30, 2023
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 5.8 years ago
Interventions
SOLTIVE™ Premium SuperPulsed Laser Fiber Systemdevice
SOLTIVE™ SuperPulsed Laser Fiber System and SOLTIVE™ Laser Fibers for single-use only